<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00963911</url>
  </required_header>
  <id_info>
    <org_study_id>CDR0000637122</org_study_id>
    <secondary_id>IB-ONCODAGE</secondary_id>
    <secondary_id>IB 2008-06</secondary_id>
    <secondary_id>RECF0891</secondary_id>
    <nct_id>NCT00963911</nct_id>
  </id_info>
  <brief_title>Questionnaire in Screening Older Patients With Cancer</brief_title>
  <official_title>Validation of a Screening Tool in Geriatric Oncology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Bergonié</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute (NCI)</source>
  <brief_summary>
    <textblock>
      RATIONALE: A screening questionnaire may help doctors plan better treatment for older
      patients with cancer.

      PURPOSE: This clinical trial is studying a questionnaire in screening older patients with
      cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

      Primary

        -  Validate a new screening tool (G8).

      Secondary

        -  Validate the French version of the screening tool &quot;Vulnerable Elders Survey (VES-13)&quot;.

        -  Evaluate the merits of the screening tools (G8 and VES-13).

        -  Assess the screening tool in specific populations.

        -  Assess the number and type of interventions proposed after thorough geriatric
           assessment.

        -  Compare the two new tools (G8 vs VES-13).

      OUTLINE: This is a multicenter study.

      During the first consultation, patients have an initial clinical evaluation questionnaire
      comprising the G8. They also complete the self-questionnaire VES-13. Within 30 days, patients
      have a thorough geriatric assessment, including quality of life and physical function, by a
      physician without access to the G8 or VES-13 questionnaires. A blood specimen is also
      collected.

      Information on health status and quality of life is collected from medical records or from
      the doctor after 1 and 5 years.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Validation of G8 screening tool</measure>
  </primary_outcome>
  <enrollment type="Anticipated">1650</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Colorectal Cancer</condition>
  <condition>Head and Neck Cancer</condition>
  <condition>Lung Cancer</condition>
  <condition>Lymphoma</condition>
  <condition>Prostate Cancer</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>medical chart review</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>screening questionnaire administration</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>comparison of screening methods</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>quality-of-life assessment</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  Histologically confirmed cancer including the following types:

               -  Colon

               -  Rectal

               -  Lung

               -  Squamous cell carcinoma of the head and neck

               -  Breast

               -  Prostate

               -  Non-Hodgkin lymphoma

          -  Planning to undergo first-time treatment comprising medicine, surgery, or radiotherapy

        PATIENT CHARACTERISTICS:

          -  No persons deprived of liberty or under guardianship

          -  No psychological, familial, social, or geographical reasons that would make monitoring
             clinically impossible

        PRIOR CONCURRENT THERAPY:

          -  See Disease Characteristics
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre Soubeyran, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut Bergonié</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institut Bergonie</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 21, 2009</study_first_submitted>
  <study_first_submitted_qc>August 21, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2009</study_first_posted>
  <last_update_submitted>May 12, 2011</last_update_submitted>
  <last_update_submitted_qc>May 12, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 13, 2011</last_update_posted>
  <keyword>colon cancer</keyword>
  <keyword>rectal cancer</keyword>
  <keyword>non-small cell lung cancer</keyword>
  <keyword>small cell lung cancer</keyword>
  <keyword>hypopharyngeal squamous cell carcinoma</keyword>
  <keyword>laryngeal squamous cell carcinoma</keyword>
  <keyword>laryngeal verrucous carcinoma</keyword>
  <keyword>lip and oral cavity squamous cell carcinoma</keyword>
  <keyword>oral cavity verrucous carcinoma</keyword>
  <keyword>nasopharyngeal squamous cell carcinoma</keyword>
  <keyword>oropharyngeal squamous cell carcinoma</keyword>
  <keyword>paranasal sinus and nasal cavity squamous cell carcinoma</keyword>
  <keyword>salivary gland squamous cell carcinoma</keyword>
  <keyword>prostate cancer</keyword>
  <keyword>breast cancer</keyword>
  <keyword>adult non-Hodgkin lymphoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Prostatic Neoplasms</mesh_term>
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

